Feedback
Settings

Settings

Goto Application

93,405 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

SDG-GoodHealth-Diabete-KO

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 9,341
1.1020090117153SYSTEM AND A METHOD FOR SEMI AUTOMATIC RESPONSE OF CLINICAL DECISION SUPPORT SYSTEM IN MANAGEMENT OF BLOOD SUGAR, PARTICULARLY FOR ANALYZING, JUDGING, AND CLASSIFYING THE BLOOD SUGAR TEST RESULTS
KR - 12.11.2009
Int.Class G06Q 50/00
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
QINFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
50Information and communication technology specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
 Appl.No 1020080043066 Applicant CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION Inventor YOON, KUN HO
PURPOSE: A system and a method for semi automatic response of clinical decision support system in management of blood sugar are provided to easily grasp the current status of diabetes patients by producing a list of patients who need intensive care, and reporting the list to a medical team. CONSTITUTION: A patient condition monitoring unit(11) extracts the blood sugar information which makes the state of the diabetes patient from a monitoring. A filtering unit(12) filters the extracted blood sugar information. A patient condition determining unit(13) processes the patient condition by good, not-decided and not-good states. A health status notifying unit(14) notifies the information about the patient judged as the health status to a patient terminal(30). COPYRIGHT KIPO 2010
2.1020150110924인슐린 통합정보관리 플랫폼을 이용한 혈당관리 시스템
KR - 05.10.2015
Int.Class G06Q 50/22
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
QINFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
50Information and communication technology specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
10Services
22Social work or social welfare, e.g. community support activities or counselling services
 Appl.No 1020140033302 Applicant 주식회사 인와이저 Inventor 김대현
본 발명은 인슐린 통합정보관리 플랫폼을 이용한 혈당관리 시스템에 관한 것으로서, 더욱 상세하게는 인슐린통합정보관리 플랫폼에서 제공하는 혈당관리 스마트 앱 또는 웹사이트를 이용하여, 인슐린 및 혈당측정 정보 등의 분석 데이터를 그래픽 기반의 사용자 UI(User Interface)를 통해 다양하게 제공받음으로써 사용자의 혈당관리를 효율적으로 할 수 있는, 인슐린 통합정보관리 플랫폼을 이용한 혈당관리 시스템에 관한 것이다. 본 발명에 따른 인슐린통합정보관리 플랫폼을 이용한 인슐린펌프 제어시스템은, 근거리 무선통신을 가능하게 하는 블루투스 통신부와 내부 전반적인 동작을 제어하는 u-컨트롤러가 구비된 인슐린펌프와; 상기 인슐린펌프와 연동되는 혈당관리 스마트 앱이 설치되며, 상기 인슐린펌프로부터 인슐린펌프 관련정보를 수신, 저장하는 휴대용 스마트단말기와; 상기 혈당관리 스마트 앱과 연동되며, API(Application Programming Interface)를 기반으로 상기 휴대용 스마트단말기로부터 상기 인슐린펌프 관련정보를 제공받으며, 상기 제공된 인슐린펌프 관련정보를 기초로 분석 및 통계정보를 생성하여 상기 휴대용 스마트단말기에 제공하는 인슐린 통합정보관리 플랫폼;을 포함하는 것을 특징으로 한다.
3.1020110057642BLOOD SUGAR MONITORING SYSTEM USING A CRADLE DEVICE AND BLOOD SUGAR MONITORING METHOD CAPABLE OF ENABLING A USER TO REMOTELY RECEIVE BLOOD A SUGAR MANAGEMENT SERVICE
KR - 01.06.2011
Int.Class A61B 5/145
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes ; Identification of persons
145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
 Appl.No 1020090114118 Applicant INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YEUNGNAM UNIVERSITY Inventor KIM, YOUNG TAK
PURPOSE: A blood sugar monitoring system using a cradle device and a blood sugar monitoring method are provided to update blood sugar information according to a user by using receiving time different between the blood sugar information and the user identification. CONSTITUTION: Blood sugar information is received from a blood sugar measuring device(S430). User identification information is inputted from the outside(S440). The time difference between the blood sugar information receiving time and the user identification information inputting time is compared with reference time. If the time difference is smaller than the reference time, the blood sugar information and the user identification information are transmitted to the management server(S450,S480). COPYRIGHT KIPO 2011
4.WO/2025/100779BIOMARKER COMPOSITION FOR EARLY DIAGNOSIS OF DIABETIC NEUROPATHY
WO - 15.05.2025
Int.Class G01N 33/68
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
 Appl.No PCT/KR2024/015864 Applicant INDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY Inventor CHO, Ho Chan
The present invention relates to: a biomarker composition for early diagnosis of diabetic neuropathy, comprising an agent for measuring the level of CA 15-3; a kit; and a method for providing information for early diagnosis of diabetic neuropathy, and can be effectively used for early prediction and diagnosis of diabetic neuropathy.
5.1020110059142APPARATUS FOR ADMINISTRATING INSULIN THROUGH REAL TIME BLOOD GLUCOSE MEASUREMENT AND A BLOOD GLUCOSE MANAGEMENT SYSTEM
KR - 02.06.2011
Int.Class A61M 5/168
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
5Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
 Appl.No 1020090115785 Applicant INDUSTRY-UNIVERSITY COOPERATION FOUNDATION SOGANG UNIVERSITY Inventor LEE, KIE JIN
PURPOSE: An apparatus for administrating insulin and a blood glucose management system are provided to optimize an insulin dosage amount based on a real time blood sugar measurement result. CONSTITUTION: An apparatus for administrating insulin comprises: a blood sugar measuring part(110) which radiates an electric wave through a blood sugar sensor and measures the blood glucose amount of an object using the electric wave reflected from the object; and an insulin pump part(120) which calculates an insulin dosage amount corresponding to the measured blood glucose amount and injects the calculated insulin dosage amount into the human body. The blood sugar measuring part includes an electric wave generating unit(112), a human body insertion type blood sugar sensor unit, and a blood glucose amount calculation unit(116). COPYRIGHT KIPO 2011
6.1020250068980당뇨병성 신경병증 조기 진단용 바이오마커 조성물
KR - 19.05.2025
Int.Class G01N 33/68
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
 Appl.No 1020230155153 Applicant 계명대학교 산학협력단 Inventor 조호찬
본 발명은 CA 15-3의 수준을 측정하는 제제를 포함하는 당뇨병성 신경병증 조기 진단용 바이오마커 조성물, 키트 및 당뇨병성 신경병증 조기 진단을 위한 정보 제공 방법에 관한 것으로, 당뇨병성 신경병증을 조기에 예측 및 진단에 유용하게 활용될 수 있다.
7.1020200024263고혈당증의 치료 및 예방을 위한 펩타이드
KR - 06.03.2020
Int.Class C12N 9/12
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
10Transferases (2.)
12transferring phosphorus containing groups, e.g. kinases (2.7)
 Appl.No 1020207002727 Applicant 위니베르시떼 드 스트라스부르 Inventor 마리옹, 뱅상
본 발명은 진성 당뇨병(diabetes mellitus) 및 연관된 장애의 치료 또는 예방을 위한 펩타이드에 관한 것이다.
8.1020220032165COMPOSITION CONTAINING RADISH LEAF EXTRACT FOR INHIBITING ADVANCED GLYCATION END PRODUCTS
KR - 15.03.2022
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
 Appl.No 1020200113602 Applicant 한국식품연구원 Inventor HA SANG KEUN
The present invention relates to a food composition containing a radish leaf extract as an active ingredient for inhibiting production of advanced glycation end products (AGEs), or inhibiting cross-linking, cutting, or decomposing AGEs; a food composition and a health supplement containing a radish leaf extract as an active ingredient for preventing or mitigating diseases related to AGEs, controlling blood pressure, reducing cholesterol, enhancing joint or bone health, controlling blood sugar, reducing blood triglyceride, improving skin condition, or providing antioxidant or anti-inflammatory effects; and a pharmaceutical composition containing a radish leaf extract as an active ingredient for preventing or treating diseases related to AGEs. According to the present invention, a radish leaf extract is excellent in activity of inhibiting formation and accumulation of AGEs and provides an effect of inhibiting cross-linking between AGEs and collagen, and cutting and decomposing AGEs, thereby being used for inhibiting production and cross-linking of AGEs or cutting or decomposing the AGEs and being usefully used in manufacture of food and medicine for preventing, mitigating, or treating diseases caused by AGEs. COPYRIGHT KIPO 2023
9.1020050039326INSULIN PUMP COMBINED WITH A MOBILE COMMUNICATION TERMINAL CAPABLE OF MEASURING A BLOOD SUGAR AND A NETWORK SYSTEM FOR TRANSMITTING CONTROL INFORMATION OF THE INSULIN PUMP, PARTICULARLY FOR PROVIDING BLOOD SUGAR MEASUREMENT INFORMATION OF A PATIENT TO A MEDICAL SERVER THROUGH THE MOBILE COMMUNICATION TERMINAL, RECEIVING INSULIN INJECTION QUANTITY INFORMATION FROM THE MEDICAL SERVER, AND CONTROLLING THE INSULIN PUMP ON THE BASIS OF INSULIN INJECTION QUANTITY INFORMATION
KR - 29.04.2005
Int.Class H04B 1/40
HELECTRICITY
04ELECTRIC COMMUNICATION TECHNIQUE
BTRANSMISSION
1Details of transmission systems, not covered by a single one of groups H04B3/-H04B13/123; Details of transmission systems not characterised by the medium used for transmission
38Transceivers, i.e. devices in which transmitter and receiver form a structural unit and in which at least one part is used for functions of transmitting and receiving
40Circuits
 Appl.No 1020030074763 Applicant KJ HEALTH CARE CO., LTD. Inventor KIM, YOON NYUN

PURPOSE: An insulin pump combined with a mobile communication terminal capable of measuring a blood sugar and a network system for transmitting control information of the insulin pump are provided to increase the use convenience of the insulin pump and supply insulin with accuracy capacity by providing blood sugar measurement information of a patient to a medical server through the mobile communication terminal, receiving insulin injection quantity information from the medical server, and controlling the insulin pump on the basis of insulin injection quantity information.

CONSTITUTION: A database(209) stores insulin injection quantity information corresponding to blood sugar measurement information, meal quantity information and exercise quantity information. A blood sugar management server(207) receives blood sugar measurement information measured in a mobile communication terminal(211), and receives meal quantity information and exercise quantity information inputted through the mobile communication terminal(211). The blood sugar management server(207) extracts insulin injection quantity information corresponding to blood sugar measurement information, meal quantity information and exercise quantity information from the database(209), and generates caller information of the mobile communication terminal(211). A communication server(203) converts insulin injection quantity information into insulin injection information coded according to a certain protocol, and transmits coded insulin injection information to the mobile communication terminal(211) corresponding to caller information.

© KIPO 2006

10.1020240075054고사리 추출물을 유효성분으로 포함하는 최종당화산물 억제용 조성물
KR - 29.05.2024
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
 Appl.No 1020220155624 Applicant 한국식품연구원 Inventor 허진영
본 발명은 고사리 추출물을 유효성분으로 포함하는 최종당화산물 생성 억제 또는 최종당화산물의 교차결합 억제, 절단 또는 분해용 식품 조성물; 고사리 추출물을 유효성분으로 포함하는 최종당화산물 관련 질환의 예방 또는 개선용, 혈압조절용, 콜레스테롤 개선용, 관절 또는 뼈 건강 개선용, 혈당조절용, 혈중중성지방 개선용, 피부상태 개선용, 항산화용, 또는 항염증용 식품 조성물 및 건강기능식품; 및 고사리 추출물을 유효성분으로 포함하는 최종당화산물 관련 질환의 예방 또는 치료용 약학적 조성물에 관한 것이다. 본 발명에 따른 고사리 추출물은 최종당화산물의 생성 및 축적 활성이 우수하고, 최종당화산물과 콜라겐의 교차결합 억제, 절단 및 분해 효과도 나타내는바, 고사리 추출물을 포함하는 조성물은 최종당화산물 생성 억제 또는 최종당화산물의 교차결합 억제, 절단 또는 분해용으로 사용될 수 있을 뿐만 아니라, 최종당화산물로 유발되는 질환의 예방, 개선 또는 치료를 위한 식품 및 의약품 제조에 유용하게 사용될 수 있다.
# -